Maintenance immunotherapy in advanced urothelial cancer
Advanced urothelial carcinoma usually responds to platinum-based chemotherapy (CT), although overall survival (OS) and progression-free survival are typically short. Immunotherapy is a promising treatment strategy, but the first-line benefits in platinum-eligible patients are limited, and its combin...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Permanyer
2022-07-01
|
| Col·lecció: | Gaceta Mexicana de Oncología |
| Matèries: | |
| Accés en línia: | https://www.gamo-smeo.com/frame_esp.php?id=323 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|